Literature DB >> 23949295

Clinical and laboratory predictors of outcome in cerebral malaria in suburban Nigeria.

Oludare Isaac Oluwayemi1, Biobele Jotham Brown, Olusola Adetunji Oyedeji, Samuel Ademola Adegoke, Olusegun Joseph Adebami, Gabriel Adebami Oyedeji.   

Abstract

INTRODUCTION: Cerebral malaria (CM) is an important cause of morbidity and mortality among children living in the tropics. The present study was conducted to update the knowledge on cerebral malaria in children.
METHODOLOGY: This was a prospective study conducted between June 2009 and February 2010. Consecutive children who met the clinical and parasitological diagnostic criteria for CM were admitted and studied. Demographic, essential history, clinical examination findings and laboratory results were recorded and analyzed. Outcome in survivors (presence or absence of neurological deficits) were determined at discharge.
RESULTS: Out of 1,202 children admitted during the study period, 66 (5.5%) had CM: 40 boys and 26 girls. Ages ranged from 2 to 128 months (mean: 41.6 ± 27.1 months). Fever (100%), coma (100%) and convulsion (89%) were the commonest presenting symptoms, while unsteady gait, speech, auditory and visual impairment were the commonest neurological deficits at discharge. Fifty-seven (86.4%) patients survived while nine (13.6%) died. Of the 57 survivors, 35 (61.4%) recovered completely, while 22 (38.6%) had neurological deficits at discharge. Identified clinical and laboratory predictors of mortality in CM included: age less than 3 years (p = 0.031), abnormal breathing pattern (p = 0.023), absent corneal reflex (p = 0.005), absent pupillary reflex (p = 0.047), retinal haemorrhage (p = 0.029), hypoglycaemia (p = 0.002) and leucocytosis (p = 0.040).
CONCLUSION: CM is associated with high mortality and serious sequelae. Affected children should be given proactive management and monitored closely to reduce the frequency of adverse outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23949295     DOI: 10.3855/jidc.2769

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Pattern of malaria in hospitalized children in Khartoum state.

Authors:  Hasan Awadalla Hashim; Eltigani Mohamed Ahmed Ali
Journal:  Sudan J Paediatr       Date:  2017

2.  Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.

Authors:  Sokhna Keita Alassane; Marie-Laure Nicolau-Travers; Sandie Menard; Olivier Andreoletti; Jean-Pierre Cambus; Noémie Gaudre; Myriam Wlodarczyk; Nicolas Blanchard; Antoine Berry; Sarah Abbes; David Colongo; Babacar Faye; Jean-Michel Augereau; Caroline Lacroux; Xavier Iriart; Françoise Benoit-Vical
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

3.  Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria.

Authors:  João L Silva-Filho; Celso Caruso-Neves; Ana A S Pinheiro
Journal:  Front Cell Infect Microbiol       Date:  2017-02-16       Impact factor: 5.293

4.  A Hospital-Based Retrospective Comparative Study of Complications, Outcomes, Clinical and Laboratory Parameters of Malaria with and without Neurological Involvement.

Authors:  Sohaib Ahmad; Nadia Shirazi; Nowneet K Bhat; Minakshi Dhar; Garima Mittal; Manish Mittal; Nidhi Kaeley; Manoj Kumar
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

5.  Cerebrospinal fluid Plasmodium falciparum histidine-rich protein-2 in pediatric cerebral malaria.

Authors:  Kiran T Thakur; Jimmy Vareta; Kathryn A Carson; Samuel Kampondeni; Michael J Potchen; Gretchen L Birbeck; Ian MacCormick; Terrie Taylor; David J Sullivan; Karl B Seydel
Journal:  Malar J       Date:  2018-03-23       Impact factor: 2.979

6.  Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.

Authors:  Tovah N Shaw; Phillip J Stewart-Hutchinson; Patrick Strangward; Durga B Dandamudi; Jonathan A Coles; Ana Villegas-Mendez; Julio Gallego-Delgado; Nico van Rooijen; Egor Zindy; Ana Rodriguez; James M Brewer; Kevin N Couper; Michael L Dustin
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.